Scientists track experimental MS Drug's path through healthy men
NCT ID NCT04171310
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 31 times
Summary
This study looked at how healthy men process a single dose of an experimental drug for multiple sclerosis. Six men took a radioactive-labeled version of the drug so researchers could measure how much left the body in urine and stool, and how the drug was broken down. The main goal was to understand the drug's journey, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number 8260001
Nottingham, United Kingdom
Conditions
Explore the condition pages connected to this study.